Opendata, web and dolomites

INVESTIGERFE SIGNED

Investigating the regulation of iron homeostasis by erythroferrone and therapeutic applications

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 INVESTIGERFE project word cloud

Explore the words cloud of the INVESTIGERFE project. It provides you a very rough idea of what is the project "INVESTIGERFE" about.

homeostasis    therapies    rheumatoid    benefits    molecules    infections    opened    anemias    prerequisite    erythroid    intensifies    examine    identification    showed    models    cancer    beta    sought    triggered    regulator    axes    tremendous    envision    manipulation    thalassemias    mice    frequent    receptor    suppresses    model    confirmed    regulatory    leads    hepcidin    signaling    synthesis    biomedical    ineffective    proof    treatments    thalassemic    erythroferrone    search    antagonization    chronic    arthritis    restricted    regulators    action    first    abortus    thalassemia    pathologies    iron    treatment    hormone    delineating    agonist    suppressed    blood    recovery    1950s    disease    existence    contribution    advantage    kidney    red    antagonist    inflammatory    disorders    cells    absorption    loading    mechanism    levels    secondary    release    anemia    assay    bowel    meet    human    overload    erythron    mouse    therapy    murine    erfe    stores    independent   

Project "INVESTIGERFE" data sheet

The following table provides information about the project.

Coordinator
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 

Organization address
address: RUE DE TOLBIAC 101
city: PARIS
postcode: 75654
website: www.inserm.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 1˙499˙235 €
 EC max contribution 1˙499˙235 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2016-STG
 Funding Scheme ERC-STG
 Starting year 2017
 Duration (year-month-day) from 2017-05-01   to  2022-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) coordinator 1˙499˙235.00

Map

 Project objective

The existence of an “erythron-related regulator” that intensifies iron absorption and its release from stores to meet the requirements for red blood cells synthesis was proposed in the 1950s. Delineating this mechanism is of high biomedical importance as the pathway could be targeted to develop novel treatments for iron-restricted anemias that are very frequent but for which current therapies are ineffective (e.g. infections, inflammatory bowel disease, cancer, or chronic kidney disease) and for iron-loading anemias (e.g. thalassemias). We have recently identified the hormone erythroferrone (ERFE) and showed that it could be the long-sought erythroid regulator of iron homeostasis. ERFE suppresses the synthesis of the iron-regulatory hormone hepcidin to facilitate the recovery from anemia but leads to secondary iron overload in β-thalassemia. The potential of ERFE in the treatment of iron disorders is tremendous but understanding its mechanism of action is a prerequisite to envision ERFE-based therapies. The identification of ERFE has opened new research areas and our project will be organized around four axes. 1) Develop an assay to measure ERFE levels in human pathologies. Its contribution is not known and needs to be confirmed. 2) Identify the receptor for ERFE, the signaling pathways triggered by ERFE, and molecules with agonist/antagonist effects, a prerequisite in the development of new therapies. 3) Search for potential other erythroid regulators. We will take advantage of the Erfe-/- mice to determine whether hepcidin could be suppressed by an ERFE-independent mechanism. 4) Study the potential of ERFE manipulation in therapy in the mouse. We will first establish a proof of principle in a mouse model of anemia (B. abortus). The benefits of ERFE antagonization will be addressed in thalassemic mice. We will also examine the role of ERFE in murine models of chronic anemia: chronic kidney disease, inflammatory bowel disease, rheumatoid arthritis and infections.

 Publications

year authors and title journal last update
List of publications.
2019 Sabrina Bondu, Anne-Sophie Alary, Carine Lefèvre, Alexandre Houy, Grace Jung, Thibaud Lefebvre, David Rombaut, Ismael Boussaid, Abderrahmane Bousta, François Guillonneau, Prunelle Perrier, Samar Alsafadi, Michel Wassef, Raphaël Margueron, Alice Rousseau, Nathalie Droin, Nicolas Cagnard, Sophie Kaltenbach, Susann Winter, Anne-Sophie Kubasch, Didier Bouscary, Valeria Santini, Andrea Toma, Mathild
A variant erythroferrone disrupts iron homeostasis in SF3B1 -mutated myelodysplastic syndrome
published pages: eaav5467, ISSN: 1946-6234, DOI: 10.1126/scitranslmed.aav5467
Science Translational Medicine 11/500 2020-01-30
2019 Irene Artuso, Mariateresa Pettinato, Antonella Nai, Alessia Pagani, Ugo Sardo, Benjamin Billoré, Maria Rosa Lidonnici, Cavan Bennett, Giacomo Mandelli, Sant-Rayn Pasricha, Giuliana Ferrari, Clara Camaschella, Léon Kautz, Laura Silvestri
Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice
published pages: e87-e90, ISSN: 0390-6078, DOI: 10.3324/haematol.2018.199810
Haematologica 104/3 2020-01-30

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INVESTIGERFE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INVESTIGERFE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

REPLAY_DMN (2019)

A theory of global memory systems

Read More  

E-DIRECT (2020)

Evolution of Direct Reciprocity in Complex Environments

Read More  

TechChild (2019)

Just because we can, should we? An anthropological perspective on the initiation of technology dependence to sustain a child’s life

Read More